Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson; Jefferey L. Burgess; Allison L. Naleway; Harmony Tyner; Sarang K. Yoon; Jennifer Meece; Lauren E.W. Olsho; Alberto J. Caban-Martinez; Ashley L. Fowlkes; Karen Lutrick; Holly C. Groom; Kayan Dunnigan; Marilyn J. Odean; Kurt Hegmann; Elisha Stefanski; Laura J. Edwards; Natasha Schaefer-Solle; Lauren Grant; Katherine Ellingson; Jennifer L. Kuntz; Tnelda Zunie; Matthew S. Thiese; Lynn Ivacic; Meredith G. Wesley; Julie Mayo Lamberte; Xiaoxiao Sun; Michael E. Smith; Andrew L. Phillips; Kimberly D. Groover; Young M. Yoo; Joseph Gerald; Rachel T. Brown; Meghan K. Herring; Gregory Joseph; Shawn Beitel; Tyler C. Morrill; Josephine Mak; Patrick Rivers; Brandon P. Poe; Brian Lynch; Yingtao Zhou; Jing Zhang; Anna Kelleher; Yan Li; Monica Dickerson; Erika Hanson; Kyley Guenther; Suxiang Tong; Allen Bateman; Erik Reisdorf; John Barnes; Eduardo Azziz-Baumgartner; Danielle R. Hunt; Melissa L. Arvay; Preeta Kutty; Alicia M. Fry; Manjusha Gaglani

Journal ArticleOPEN ACCESS

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Thompson M
Burgess J
Naleway A
et al.

New England Journal of Medicine (2021) 385(4) 320-329

DOI: 10.1056/nejmoa2107058

349Citations

528Readers

Get full text

Abstract

Abstract Background Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with ...

Cite

CITATION STYLE

APA

Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., … Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine, 385(4), 320–329. https://doi.org/10.1056/nejmoa2107058

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Abstract

Cite

Register to see more suggestions